ID

15075

Description

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470; ODM derived from: https://clinicaltrials.gov/show/NCT02302443

Link

https://clinicaltrials.gov/show/NCT02302443

Keywords

Versions (1)
  1. 5/14/16 5/14/16 -
Uploaded on

May 14, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus NCT02302443

English

Eligibility Diabetes Mellitus NCT02302443

1 forms  
Criteria
Description

Criteria

t2dm more than 12 monthm
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
age ≥18 and ≤70 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
body mass index between 18.0 and 35.0 kg/m2 inclusive.
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
Description

Healthy | Medical History | Physical Examination | Biochemical finding

Data type

boolean

Alias
UMLS CUI [1]
C3898900
UMLS CUI [2]
C0262926
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0428132
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
Description

Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0086287
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0041275
UMLS CUI [6]
C0020699
UMLS CUI [7]
C2243030
UMLS CUI [8]
C0278321
UMLS CUI [9]
C0232970
UMLS CUI [10]
C0086582
UMLS CUI [11]
C0024559
UMLS CUI [12]
C0036899
UMLS CUI [13]
C3831118
UMLS CUI [14]
C0700589
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
Description

Informed Consent | Research Activities

Data type

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0242481
inclusion criteria for t2dm:
Description

Inclusion | Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C1512693
UMLS CUI [2]
C0011860
t1dm more than 12 monthm
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
age ≥18 and ≤70 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
body mass index between 18.0 and 30.0 kg/m2 inclusive.
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
Description

Healthy | Medical History | Physical Examination | Biochemical finding

Data type

boolean

Alias
UMLS CUI [1]
C3898900
UMLS CUI [2]
C0262926
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0428132
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
Description

Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0086287
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0041275
UMLS CUI [6]
C0020699
UMLS CUI [7]
C2243030
UMLS CUI [8]
C0278321
UMLS CUI [9]
C0232970
UMLS CUI [10]
C0086582
UMLS CUI [11]
C0024559
UMLS CUI [12]
C0036899
UMLS CUI [13]
C3831118
UMLS CUI [14]
C0700589
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
Description

informed consent | Research Activities

Data type

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0242481
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
a subject who has proliferative retinopathy or maculopathy, severe gastroparesis, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
Description

Proliferative retinopathy | Disorder of macula of retina Proliferative | Gastroparesis Severe | Neuropathy Severe | Autonomic neuropathy

Data type

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C0334094
UMLS CUI [3,1]
C0152020
UMLS CUI [3,2]
C0205082
UMLS CUI [4,1]
C0442874
UMLS CUI [4,2]
C0205082
UMLS CUI [5]
C0259749
recurrent major hypoglycemia or hypoglycemic unawareness or recent ketoacidosis
Description

Hypoglycemia Major Recurrent | Hypoglycemia unawareness | Ketoacidosis Recent

Data type

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205164
UMLS CUI [1,3]
C2945760
UMLS CUI [2]
C0342317
UMLS CUI [3,1]
C0220982
UMLS CUI [3,2]
C0332185
pregnant or lactating women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
participation in an investigational study within 30 days prior to dosing
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
clinically significant abnormal ecg at screening, as judged by the investigator
Description

Electrocardiogram abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0522055
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus NCT02302443

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Diabetes Mellitus, Non-Insulin-Dependent
Item
t2dm more than 12 monthm
boolean
C0011860 (UMLS CUI [1])
Age
Item
age ≥18 and ≤70 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index between 18.0 and 35.0 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
Healthy | Medical History | Physical Examination | Biochemical finding
Item
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
boolean
C3898900 (UMLS CUI [1])
C0262926 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0428132 (UMLS CUI [4])
Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods
Item
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
boolean
C0086287 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0041275 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C2243030 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0232970 (UMLS CUI [9])
C0086582 (UMLS CUI [10])
C0024559 (UMLS CUI [11])
C0036899 (UMLS CUI [12])
C3831118 (UMLS CUI [13])
C0700589 (UMLS CUI [14])
Informed Consent | Research Activities
Item
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
boolean
C0021430 (UMLS CUI [1])
C0242481 (UMLS CUI [2])
Inclusion | Diabetes Mellitus, Non-Insulin-Dependent
Item
inclusion criteria for t2dm:
boolean
C1512693 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent
Item
t1dm more than 12 monthm
boolean
C0011854 (UMLS CUI [1])
Age
Item
age ≥18 and ≤70 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index between 18.0 and 30.0 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
Healthy | Medical History | Physical Examination | Biochemical finding
Item
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
boolean
C3898900 (UMLS CUI [1])
C0262926 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0428132 (UMLS CUI [4])
Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods
Item
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
boolean
C0086287 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0041275 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C2243030 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0232970 (UMLS CUI [9])
C0086582 (UMLS CUI [10])
C0024559 (UMLS CUI [11])
C0036899 (UMLS CUI [12])
C3831118 (UMLS CUI [13])
C0700589 (UMLS CUI [14])
informed consent | Research Activities
Item
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
boolean
C0021430 (UMLS CUI [1])
C0242481 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Proliferative retinopathy | Disorder of macula of retina Proliferative | Gastroparesis Severe | Neuropathy Severe | Autonomic neuropathy
Item
a subject who has proliferative retinopathy or maculopathy, severe gastroparesis, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
boolean
C0339467 (UMLS CUI [1])
C0730362 (UMLS CUI [2,1])
C0334094 (UMLS CUI [2,2])
C0152020 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0442874 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0259749 (UMLS CUI [5])
Hypoglycemia Major Recurrent | Hypoglycemia unawareness | Ketoacidosis Recent
Item
recurrent major hypoglycemia or hypoglycemic unawareness or recent ketoacidosis
boolean
C0020615 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C2945760 (UMLS CUI [1,3])
C0342317 (UMLS CUI [2])
C0220982 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in an investigational study within 30 days prior to dosing
boolean
C2348568 (UMLS CUI [1])
Electrocardiogram abnormal
Item
clinically significant abnormal ecg at screening, as judged by the investigator
boolean
C0522055 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial